These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11564856)

  • 1. Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program.
    Perlman DC; Gourevitch MN; Trinh C; Salomon N; Horn L; Des Jarlais DC
    J Urban Health; 2001 Sep; 78(3):550-67. PubMed ID: 11564856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis.
    Gourevitch MN; Alcabes P; Wasserman WC; Arno PS
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia.
    Foster S; Godfrey-Faussett P; Porter J
    AIDS; 1997 Jun; 11(7):919-25. PubMed ID: 9189218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness.
    Snyder DC; Paz EA; Mohle-Boetani JC; Fallstad R; Black RL; Chin DP
    Am J Respir Crit Care Med; 1999 Jul; 160(1):178-85. PubMed ID: 10390397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of monetary incentives on adherence to referral for screening chest x-rays after syringe exchange-based tuberculin skin testing.
    Perlman DC; Friedmann P; Horn L; Nugent A; Schoeb V; Carey J; Salomon N; Des Jarlais DC
    J Urban Health; 2003 Sep; 80(3):428-37. PubMed ID: 12930881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis.
    Macintyre CR; Plant AJ; Hendrie D
    Health Econ; 2000 Jul; 9(5):411-21. PubMed ID: 10903541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR; Brehm WT; Moore RD; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
    Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
    BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in asymptomatic HIV-infected adults with abnormal chest radiographs screened for tuberculosis prevention.
    Agizew TB; Arwady MA; Yoon JC; Nyirenda S; Mosimaneotsile B; Tedla Z; Motsamai O; Kilmarx PH; Wells CD; Samandari T
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):45-51. PubMed ID: 20003694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective.
    Bell JC; Rose DN; Sacks HS
    AIDS; 1999 Aug; 13(12):1549-56. PubMed ID: 10465080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organizational issues in conducting tuberculosis screening at a syringe exchange program.
    Paone D; Perlman DC; Perkins MP; Kochems LM; Salomon N; Des Jarlais DC
    J Subst Abuse Treat; 1998; 15(3):229-34. PubMed ID: 9633035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
    Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of isoniazid chemoprevention in close contacts.
    Diel R; Nienhaus A; Schaberg T
    Eur Respir J; 2005 Sep; 26(3):465-73. PubMed ID: 16135730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TB prevention in HIV clinics in New York City.
    Sackoff JE; Torian LV; Frieden TR
    Int J Tuberc Lung Dis; 2001 Feb; 5(2):123-8. PubMed ID: 11258505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda.
    Shrestha RK; Mugisha B; Bunnell R; Mermin J; Hitimana-Lukanika C; Odeke R; Madra P; Adatu F; Blandford JM
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):656-62. PubMed ID: 16776453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.